3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
8
Gynecologic
4
Genitourinary
3
Plasma cell
2
Other hematologic neoplasm
2
Breast
2
Thoracic
1
NET
1
Lymphoid
1
Head & Neck
1
Endocrine
1
Conditions
Multiple Myeloma
494
Lymphoma
52
Recurrence
49
Neoplasms, Plasma Cell
49
Immunoglobulin Light-chain Amyloidosis
43
Neoplasms
35
Lymphoma, Non-Hodgkin
35
Leukemia
34
Hematologic Neoplasms
32
Myelodysplastic Syndromes
28
Smoldering Multiple Myeloma
27
Leukemia, Myeloid, Acute
26
Leukemia, Plasma Cell
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Monoclonal Gammopathy of Undetermined Significance
18
Hodgkin Disease
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Amyloidosis
17
Lymphoma, B-Cell
15
Breast Neoplasms
14
Ovarian Neoplasms
12
Paraproteinemias
11
Myeloproliferative Disorders
10
Colorectal Neoplasms
10
Primary Myelofibrosis
9
Melanoma
9
Lymphoma, Follicular
9
Infections
9
Prostatic Neoplasms
8
Lymphoproliferative Disorders
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Frailty
×
Plasma cell
×
Clear all
NCT06099912
2026-02-12
DynaFiT
The First Hospital of Jilin University
Recruiting
131 enrolled
NCT06247189
2025-12-22
Onco-ICOPE
University Hospital, Toulouse
Phase NA
Recruiting
30 enrolled